Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 37 Liver Neoplasms 20 Neoplasms 17 Leukemia, Myeloid, Acute 13 Neoplasm Metastasis 11 Carcinoma, Renal Cell 9 Carcinoma, Non-Small-Cell Lung 9 Pancreatic Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Melanoma 7 Breast Neoplasms 6 Brain Neoplasms 6 Unspecified Adult Solid Tumor, Protocol Specific 5 Prostatic Neoplasms 5 Multiple Myeloma 5 Lung Neoplasms 5 Kidney Neoplasms 5 Recurrence 4 Glioblastoma 4 Colorectal Neoplasms 4 Sarcoma 3 Rectal Neoplasms 3 Myelodysplastic Syndromes 3 Leukemia, Promyelocytic, Acute 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Megakaryoblastic, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Erythroblastic, Acute 3 Leukemia, Eosinophilic, Acute 3

Interventions

Nivolumab 8 Paclitaxel 6 Sirolimus 5 Bevacizumab 5 temsirolimus 4 Pemetrexed 4 Ipilimumab 4 Docetaxel 4 Carboplatin 4 ARRY-334543 4 Gemcitabine 3 Erlotinib Hydrochloride 3 olaparib 2 linrodostat 2 apatinib 2 anlotinib 2 abemaciclib 2 Vorinostat 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Everolimus 2 Doxorubicin 2 Dasatinib 2 Chlorogenic Acid 2 Cetuximab 2 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 vorolanib 1 vistusertib 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Cancer × Sorafenib × Clear all

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡